Mira Pharmaceuticals (MIRA) Research & Development (2022 - 2025)
Mira Pharmaceuticals (MIRA) recorded Research & Development of $496,543 in the quarter ended Dec 31, 2025, down 42.4% from $861,441 a year earlier but up 20.3% from the prior quarter.
Powered by 
Analysis
Mira Pharmaceuticals (MIRA) Research & Development (2022 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Mira Pharmaceuticals reported Research & Development of $1.72 million, down 48.0% from the prior year.
- Annual Research & Development has a three-year compound annual growth rate of -9.9% (years ended Dec 2022 to Dec 2025).
- Across earlier years, Research & Development came in at $3.31 million in the year ended Dec 31, 2024 (+110.1%), $1.57 million in the year ended Dec 31, 2023 (-33.1%) and $2.35 million in the year ended Dec 31, 2022.
- Quarterly Research & Development has ranged from $271,606 in the quarter ended Mar 31, 2023 to $1.07 million in the quarter ended Sep 30, 2024 over the past five years.
- On a year-over-year basis, Research & Development has declined for four consecutive quarters, with growth averaging 18.1% over the last seven quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 180.7% in the quarter ended Mar 31, 2024, against a decline of 61.3% in the quarter ended Sep 30, 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $412,639 (quarter ended Sep 30, 2025), $496,197 (quarter ended Jun 30, 2025) and $314,404 (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Mira Pharmaceuticals | 14.93 Mn | -5.58 Mn | - | 496,543.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 496,543.00 |
| Sep 30, 2025 | 412,639.00 |
| Jun 30, 2025 | 496,197.00 |
| Mar 31, 2025 | 314,404.00 |
| Dec 31, 2024 | 861,441.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 614,462.00 |
| Mar 31, 2024 | 762,276.00 |
| Dec 31, 2023 | 387,123.00 |
| Sep 30, 2023 | 1.02 Mn |
| Mar 31, 2023 | 271,606.00 |
| Dec 31, 2022 | 884,757.00 |
| Sep 30, 2022 | 714,968.00 |
API Access
Mira Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=MIRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "MIRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=MIRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();